abbvie

AbbVie (NYSE: ABBV) is a global, research-based biopharmaceutical company. AbbVie develops and markets advance therapies that address some of the world’s most complex and serious diseases. AbbVie products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson’s disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. AbbVie has also a pipeline of promising new medicines, including more than 50 compounds or indications in clinical development across such important medical specialties as immunology, virology/liver disease, oncology, neurological diseases, and women’s health. AbbVie became independent publicly traded company, which is currently a Fortune 200 company traded on the New York Stock Exchange, on January 1, 2013, as a result of the distribution by Abbott Laboratories of 100 percent of outstanding common stock of AbbVie to Abbot’s shareholders.

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas.

Important Notice: APVRS 2025 Fake or Scammer Websites and Emails

Be cautious of fake or scammer websites and emails pretending to be the official APVRS 2025 system, as these are not affiliated with us.

Please be advised that congress.2025.apvrs.org is the only official system for congress registration.

In addition, all hotel booking confirmation emails will be sent exclusively from the official APVRS email domain (@apvrs.org) or directly from the hotel. No other entities, including those claiming to be appointed travel agencies, are authorized to handle APVRS 2025 bookings.

Verify the website and sender before responding to any registration or booking-related communications. Do not disclose any personal information if you have concerns.

For assistance or inquiries, please contact the APVRS Secretariat at secretariat@apvrs.org.

Important Notice: APVRS 2025 Fake or Scammer Websites and Emails
Be cautious of fake or scammer websites and emails pretending to be the official APVRS 2025 system, as these are not affiliated with us. Please be advised that congress.2025.apvrs.org is the only official system for congress registration. In addition, all hotel booking confirmation emails will be sent exclusively from the official APVRS email domain (@apvrs.org) or directly from the hotel. No other entities, including those claiming to be appointed travel agencies, are authorized to handle APVRS 2025 bookings. Verify the website and sender before responding to any registration or booking-related communications. Do not disclose any personal information if you have concerns. For assistance or inquiries, please contact the APVRS Secretariat at secretariat@apvrs.org.